NCT03248440 - Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion | Biotech Hunter

Enrollment

263

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

August 17, 2018

Study Completion Date

August 17, 2018

Conditions

Chalazion

Interventions

DRUG

SUN-131 1.5% TDS

SUN-131 1.5% TDS will be worn for 14 days

DRUG

Placebo TDS

No active substance; Placebo TDS will be worn each day for 14 days

Trial Locations (65)

11793

SUN-131-03 Investigational Site, Wantagh

17601

SUN-131-03 Investigational Site, Lancaster

19087

SUN-131-03 Investigational Site, Lancaster

SUN-131-03 Investigational Site, Wayne

19148

SUN-131-03 Investigational Site, Philadelphia

22046

SUN-131-03 Investigational Site, Falls Church

23350

SUN-131-03 Investigational Site, Exmore

23456

SUN-131-03 Investigational Site, Norfolk

27262

SUN-131-03 Investigational Site, High Point

28210

SUN-131-03 Investigational Site, Charlotte

28803

SUN-131-03 Investigational Site, Asheville

29501

SUN-131-03 Investigational Site, Florence

30076

SUN-131-03 Investigational Site, Roswell

30260

SUN-131-03 Investigational Site, Morrow

31701

SUN-131-03 Investigational Site, Albany

32751

SUN-131-03 Investigational Site, Maitland

33321

SUN-131-03 Investigational Site, Tamarac

33773

SUN-131-03 Investigational Site, Largo

33901

SUN-131-03 Investigational Site, Fort Myers

37215

SUN-131-03 Investigational Site, Nashville

37411

SUN-131-03 Investigational Site, Chattanooga

38119

SUN-131-03 Investigational Site, Memphis

40206

SUN-131-03 Investigational Site, Louisville

40509

SUN-131-03 Investigational Site, Lexington

45040

SUN-131-03 Investigational Site, Mason

45236

SUN-131-03 Investigational Site, Cincinnati

45247

SUN-131-03 Investigational Site, Cincinnati

49085

SUN-131-03 Investigational Site, Saint Joseph

53405

SUN-131-03 Investigational Site, Racine

55420

SUN-131-03 Investigational Site, Bloomington

57701

SUN-131-03 Investigational Site, Rapid City

60026

SUN-131-03 Investigational Site, Glenview

60046

SUN-131-03 Investigational Site, Lake Villa

60169

SUN-131-03 Investigational Site, Hoffman Estates

60415

SUN-131-03 Investigational Site, Chicago Ridge

63090

SUN-131-03 Investigational Site, Washington

63131

SUN-131-03 Investigational Site, St Louis

64133

SUN-131-03 Investigational Site, Kansas City

66204

SUN-131-03 Investigational Site, Shawnee Mission

66211

SUN-131-03 Investigational Site, Leawood

77008

SUN-131-03 Investigational Site, Houston

77034

SUN-131-03 Investigational Site, Houston

77055

SUN-131-03 Investigational Site, Houston

78209

SUN-131-03 Investigational Site, San Antonio

78240

SUN-131-03 Investigational Site, San Antonio

78572

SUN-131-03 Investigational Site, Mission

78613

SUN-131-03 Investigational Site, Cedar Park

78734

SUN-131-03 Investigational Site, Lakeway

80120

SUN-131-03 Investigational Site, Littleton

80907

SUN-131-03 Investigational Site, Colorado Springs

84117

SUN-131-03 Investigational Site, Salt Lake City

85225

SUN-131-03 Investigational Site, Chandler

85351

SUN-131-03 Investigational Site, Sun City

86301

SUN-131-03 Investigational Site, Prescott

89119

SUN-131-03 Investigational Site, Las Vegas

89123

SUN-131-03 Investigational Site, Las Vegas

90048

SUN-131-03 Investigational Site, Los Angeles

90805

SUN-131-03 Investigational Site, Long Beach

91204

SUN-131-03 Investigational Site, Glendale

91345

SUN-131-03 Investigational Site, Mission Hills

92115

SUN-131-03 Investigational Site, San Diego

92705

SUN-131-03 Investigational Site, Santa Ana

93534

SUN-131-03 Investigational Site, Lancaster

94954

SUN-131-03 Investigational Site, Petaluma

95670

SUN-131-03 Investigational Site, Rancho Cordova

All Listed Sponsors

lead

Senju USA, Inc.

INDUSTRY